Antifungal drugs
J Houšť, J Spížek, V Havlíček - Metabolites, 2020 - mdpi.com
We reviewed the licensed antifungal drugs and summarized their mechanisms of action,
pharmacological profiles, and susceptibility to specific fungi. Approved antimycotics inhibit 1 …
pharmacological profiles, and susceptibility to specific fungi. Approved antimycotics inhibit 1 …
Antifungal resistance: current trends and future strategies to combat
NP Wiederhold - Infection and drug resistance, 2017 - Taylor & Francis
Antifungal resistance represents a major clinical challenge to clinicians responsible for
treating invasive fungal infections due to the limited arsenal of systemically available …
treating invasive fungal infections due to the limited arsenal of systemically available …
Scedosporium and Lomentospora: an updated overview of underrated opportunists
A Ramirez-Garcia, A Pellon, A Rementeria… - Medical …, 2018 - academic.oup.com
Abstract Species of Scedosporium and Lomentospora are considered as emerging
opportunists, affecting immunosuppressed and otherwise debilitated patients, although …
opportunists, affecting immunosuppressed and otherwise debilitated patients, although …
The changing microbial epidemiology in cystic fibrosis
JJ LiPuma - Clinical microbiology reviews, 2010 - Am Soc Microbiol
Infection of the airways remains the primary cause of morbidity and mortality in persons with
cystic fibrosis (CF). This review describes salient features of the epidemiologies of microbial …
cystic fibrosis (CF). This review describes salient features of the epidemiologies of microbial …
[图书][B] Descriptions of medical fungi
S Kidd, C Halliday, D Ellis - 2022 - books.google.com
The 4th edition of this book provides laboratory staff and clinicians with a quick benchtop
reference on the identification and antifungal susceptibility of human and animal fungal …
reference on the identification and antifungal susceptibility of human and animal fungal …
Infections Caused by Scedosporium spp
KJ Cortez, E Roilides, F Quiroz-Telles… - Clinical microbiology …, 2008 - Am Soc Microbiol
Scedosporium spp. are increasingly recognized as causes of resistant life-threatening
infections in immunocompromised patients. Scedosporium spp. also cause a wide spectrum …
infections in immunocompromised patients. Scedosporium spp. also cause a wide spectrum …
Changing epidemiology of systemic fungal infections
M Richardson, C Lass‐Flörl - Clinical microbiology and …, 2008 - Wiley Online Library
ABSTRACT Species of Candida and Aspergillus remain the most common causes of
invasive fungal infections, but other yeasts and filamentous fungi are emerging as significant …
invasive fungal infections, but other yeasts and filamentous fungi are emerging as significant …
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments
V De Stefano, T Za, E Rossi, AM Vannucchi… - …, 2008 - haematologica.org
Background Prior thrombosis is a well-established risk factor for re-thrombosis in
polycythemia vera and essential thrombocythemia but scarce data are available on the rate …
polycythemia vera and essential thrombocythemia but scarce data are available on the rate …
Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species
M Lackner, GS de Hoog, PE Verweij… - Antimicrobial Agents …, 2012 - Am Soc Microbiol
Since the separation of Pseudallescheria boydii and P. apiosperma in 2010, limited data on
species-specific susceptibility patterns of these and other species of Pseudallescheria and …
species-specific susceptibility patterns of these and other species of Pseudallescheria and …
Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis—a review
M Pihet, J Carrere, B Cimon, D Chabasse… - …, 2009 - academic.oup.com
The colonization of airways by filamentous fungi and the development of respiratory
infections require some predisposing factors as encountered in patients with cystic fibrosis …
infections require some predisposing factors as encountered in patients with cystic fibrosis …